Paper36937436
ImmuneScore of eight-gene signature predicts prognosis and survival in patients with endometrial cancer.
Gu J and 3 others. Front Oncol, 2023. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. ImmuneScore of eight-gene signature predicts prognosis and survival in patients with endometrial cancer. Papers, record 36937436. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36937436
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- ImmuneScore of eight-gene signature predicts prognosis and survival in patients with endometrial cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29385370 | Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29385370 | PubMed |
| 2 | 19542708 | [Nomogram as predictive model in clinical practice]. | Gan To Kagaku Ryoho | 2009 | https://conductscience.org/library/papers/19542708 | PubMed |
| 3 | 33407221 | Construction of a nine DNA repair-related gene prognostic classifier to predict prognosis in patients with endometrial carcinoma. | BMC Cancer | 2021 | https://conductscience.org/library/papers/33407221 | PubMed |
| 4 | 24202395 | Microenvironmental regulation of tumor progression and metastasis. | Nat Med | 2013 | https://conductscience.org/library/papers/24202395 | PubMed |
| 5 | 24176790 | The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets. | Cancer Treat Rev | 2014 | https://conductscience.org/library/papers/24176790 | PubMed |
| 6 | 34134781 | Immunotherapy in endometrial cancer: rationale, practice and perspectives. | Biomark Res | 2021 | https://conductscience.org/library/papers/34134781 | PubMed |
| 7 | 28388943 | Time-dependent ROC curve analysis in medical research: current methods and applications. | BMC Med Res Methodol | 2017 | https://conductscience.org/library/papers/28388943 | PubMed |
| 8 | 32894095 | Identification of a metabolism-related gene expression prognostic model in endometrial carcinoma patients. | BMC Cancer | 2020 | https://conductscience.org/library/papers/32894095 | PubMed |
| 9 | 31910163 | Conservative treatment in early stage endometrial cancer: a review. | Acta Biomed | 2019 | https://conductscience.org/library/papers/31910163 | PubMed |
| 10 | 29432521 | Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series. | Ann Oncol | 2018 | https://conductscience.org/library/papers/29432521 | PubMed |
| 11 | 32863946 | Reciprocal change in Glucose metabolism of Cancer and Immune Cells mediated by different Glucose Transporters predicts Immunotherapy response. | Theranostics | 2020 | https://conductscience.org/library/papers/32863946 | PubMed |
| 12 | 26224872 | Integrative Protein-Based Prognostic Model for Early-Stage Endometrioid Endometrial Cancer. | Clin Cancer Res | 2016 | https://conductscience.org/library/papers/26224872 | PubMed |
| 13 | 29663340 | Molecular signatures in hepatocellular carcinoma: A step toward rationally designed cancer therapy. | Cancer | 2018 | https://conductscience.org/library/papers/29663340 | PubMed |
| 14 | 28061006 | Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer. | Cancer | 2017 | https://conductscience.org/library/papers/28061006 | PubMed |
| 15 | 31105744 | Identification of Potential Crucial Genes Associated With the Pathogenesis and Prognosis of Endometrial Cancer. | Front Genet | 2019 | https://conductscience.org/library/papers/31105744 | PubMed |
| 16 | 31238232 | Defining a mutational signature for endometrial cancer screening and early detection. | Cancer Epidemiol | 2019 | https://conductscience.org/library/papers/31238232 | PubMed |
| 17 | 29327492 | A five-gene signature may predict sunitinib sensitivity and serve as prognostic biomarkers for renal cell carcinoma. | J Cell Physiol | 2018 | https://conductscience.org/library/papers/29327492 | PubMed |
| 18 | 30887763 | Immunotherapy in endometrial cancer: new scenarios on the horizon. | J Gynecol Oncol | 2019 | https://conductscience.org/library/papers/30887763 | PubMed |
| 19 | 32351880 | BTK Has Potential to Be a Prognostic Factor for Lung Adenocarcinoma and an Indicator for Tumor Microenvironment Remodeling: A Study Based on TCGA Data Mining. | Front Oncol | 2020 | https://conductscience.org/library/papers/32351880 | PubMed |
| 20 | 30042208 | Immunomarker Support Vector Machine Classifier for Prediction of Gastric Cancer Survival and Adjuvant Chemotherapeutic Benefit. | Clin Cancer Res | 2018 | https://conductscience.org/library/papers/30042208 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42186216 | Epithelial YPEL3 Modulates CD8+ T-Cell Infiltration and Tumor Progression Through CREB1-CXCL16 Signaling in HNSCC. | Cancer Sci | 2026 | https://conductscience.org/library/papers/42186216 | PubMed |
| 41457788 | The Role of RANBP3L in Pan-Cancer With Its Significance in Hepatocellular Carcinoma. | Cancer Rep (Hoboken) | 2026 | https://conductscience.org/library/papers/41457788 | PubMed |
| 40645995 | DLX4 regulates rheumatoid arthritis fibroblast-like synoviocytes invasiveness and a cancer transcriptomic signature. | Sci Rep | 2025 | https://conductscience.org/library/papers/40645995 | PubMed |
| 38688977 | Pan-cancer analysis reveals correlation between RAB3B expression and tumor heterogeneity, immune microenvironment, and prognosis in multiple cancers. | Sci Rep | 2024 | https://conductscience.org/library/papers/38688977 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| DLX4 | 1748 | PubTator's text mining | https://conductscience.org/library/genes/1748 | NCBI Gene |
| GAPDH | 2597 | PubTator's text mining | https://conductscience.org/library/genes/2597 | NCBI Gene |
| GFRA4 | 64096 | PubTator's text mining | https://conductscience.org/library/genes/64096 | NCBI Gene |
| KLRB1 | 3820 | PubTator's text mining | https://conductscience.org/library/genes/3820 | NCBI Gene |
| LINC03062 | 100129066 | PubTator's text mining | https://conductscience.org/library/genes/100129066 | NCBI Gene |
| NBAT1 | 729177 | PubTator's text mining | https://conductscience.org/library/genes/729177 | NCBI Gene |
| PRAC1 | 84366 | PubTator's text mining | https://conductscience.org/library/genes/84366 | NCBI Gene |
| PTPRT | 11122 | PubTator's text mining | https://conductscience.org/library/genes/11122 | NCBI Gene |
| RANBP3L | 202151 | PubTator's text mining | https://conductscience.org/library/genes/202151 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36937436
GET https://conductscience.org/api/papers/v1/36937436/references?page=2